Next-Generation Cardiac Magnetic Resonance Imaging Techniques for Characterization of Myocardial Disease

Abstract

Purpose of the Review Many novel cardiac magnetic resonance imaging (cMR) techniques have been developed for diagnosis, risk stratification, and monitoring of myocardial disease. The field is changing rapidly with advances in imaging technology. The purpose of this review is to give an update on next-generation cMR techniques with promising developments for clinical translation in the last two years, and to outline clinical applications. Recent Findings There has been increasing widespread clinical adoption of T1/T2 mapping into standard of care clinical practice. Development of auto segmentation has enabled clinical integration, with potential applications to minimize the use of contrast. Advances in diffusion tensor imaging, multiparametric mapping with cardiac MRI fingerprinting, automated quantitative perfusion mapping, metabolic imaging, elastography, and 4D flow are advancing the ability of cMR to provide further quantitative characterization to enable deep myocardial disease phenotyping. Together these advanced imaging features further augment the ability of cMR to contribute to novel disease characterization and may provide an important platform for personalized medicine. Summary Next-generation cMR techniques provide unique quantitative imaging features that can enable the identification of imaging biomarkers that may further refine disease classification and risk prediction. However, widespread clinical application continues to be limited by ground truth validation, reproducibility of the techniques across vendor platforms, increased scan time, and lack of widespread availability of advanced cardiac MRI physicists and expert readers. However, these techniques show great promise in minimizing the need for invasive testing, may elucidate novel pathophysiology, and may provide the ability for more accurate diagnosis of myocardial disease.